no image available Dickens & Co. "Beating the Odds: The Miraculous Response to Brentuximab Vedotin in Recalcitrant Cutaneous T-Cell Lymphomas" "The potent cocktail of hope for patients with epidermotropic cutaneous T-cell lymphomas (ETCL) when all else fails" Price: 22.00€